Invention Grant
US08258272B2 Agent for controlling Bcl-2 expression comprising ginsenoside F1 as an active component
有权
用于控制包含人参皂苷F1作为活性成分的Bcl-2表达的药剂
- Patent Title: Agent for controlling Bcl-2 expression comprising ginsenoside F1 as an active component
- Patent Title (中): 用于控制包含人参皂苷F1作为活性成分的Bcl-2表达的药剂
-
Application No.: US12135663Application Date: 2008-06-09
-
Publication No.: US08258272B2Publication Date: 2012-09-04
- Inventor: Si-Young Cho , Eun-Hee Lee , Su-Jung Kim , Eui-Seok Shin , Hui-Kyoung Chang , Duck-Hee Kim , Myeong Hoon Yeom , Kwang-Sik Woe , Tae-Ryong Lee , Young-Chul Sim
- Applicant: Si-Young Cho , Eun-Hee Lee , Su-Jung Kim , Eui-Seok Shin , Hui-Kyoung Chang , Duck-Hee Kim , Myeong Hoon Yeom , Kwang-Sik Woe , Tae-Ryong Lee , Young-Chul Sim
- Applicant Address: KR Seoul
- Assignee: Amorepacific Corporation
- Current Assignee: Amorepacific Corporation
- Current Assignee Address: KR Seoul
- Agency: Sughrue Mion, PLLC
- Priority: KR10-2002-0085716 20021228
- Main IPC: A61K31/704
- IPC: A61K31/704 ; A61P17/00 ; C07J17/00
Abstract:
The present invention relates to an agent for controlling Bcl-2 expression comprising ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) represented by the following formula 1 as an active component.
Public/Granted literature
- US20080261899A1 AGENT FOR CONTROLLING Bcl-2 EXPRESSION COMPRISING GINSENOSIDE F1 AS AN ACTIVE COMPONENT Public/Granted day:2008-10-23
Information query
IPC分类:
